- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05623462
Virtual Reality Training for Walking Improvement in the Elderly
Virtual Reality Treadmill Training for Improving Gait Performance in the Elderly
Safe walking needs the older adult to anticipate and respond quickly to external demands and sudden environmental changes. The practice of complex and challenging situations of the usual daily walking is very important to prevent balance loss and falls in the elderly.
Researchers reported that subjects trained in a virtual environment with enhanced feedback performed walking skills better than those trained with conventional methods. The C-Mill treadmill is an innovative device that was recently used for the training of impaired gait and balance. C-Mill treadmill uses virtual reality, augmented feedback, and force plate technology that provides the best solution for efficient functional movement therapy. Therefore, this study will evaluate the efficacy of gait training with a virtual reality treadmill on walking abilities in elderly people.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Many studies have shown that walking exercises effectively contribute to enhancing walking performance in the elderly. Several studies have shown that treadmill training is effective in improving the elderly person's ability to walk. Therefore, the practice of complex and challenging situations of the usual daily walking is very important to improve walking. Unfortunately, older adults have few opportunities to practice safe walking well and consistently in a task-specific manner.
There are many studies that have shown that gait training in a challenging environment, such as walking on a treadmill, is more effective in improving the elderly person's ability to walk properly, compared to the traditional training exercise regimen that relies on training in closed training environment free from challenges and obstacles.
Virtual reality technology is one of the advanced technologies used in physical therapy and rehabilitation. This technology contributes to creating an interactive environment for the trainees that enables them to integrate into the training process and encourages them to perform controlled motor tasks. C-Mill treadmill applies a virtual reality environment, dual-tasking exercises, obstacle avoidance games, and a variety of gait challenges in a safe and controlled environment to increase walking adaptability and improve performance in everyday life. Many studies found that the C-Mill treadmill is effective in improving gait performance and adaptability in clinical practice Therefore, this study will compare the efficacy of gait training with a virtual reality treadmill and the conventional physical therapy program on walking abilities in elderly people.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mecca, Saudi Arabia, 21955
- Ehab Mohamed Abd El Kafy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
40 healthy older adults, both sexes, will participate in this study. Their ages will be between 65 to 75 years. They should have stable medical status based on a confirmed written medical report signed by their physicians. All participants should not receive other training to improve their balance and gait during the duration of the study application except through this study training program.
Exclusion Criteria:
The exclusion criteria will include any participant with:
- a cognitive reduction (< 23 points based on the Mini-Mental State Examination scale;
- muscle paralysis,
- fixed lower limb bony deformities,
- balance deficits,
- visual problems,
- diabetes mellitus,
- polyneuropathy,
- gait disorders,
- using assistive walking devices during walking,
- vertigo, anti-seizures drug use and hypertension,
- vestibular and cerebellar problems; and
- auditory and perceptual diseases/impairments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group
Participants in the control group will receive conventional gait training (conventional physical therapy program) for one hour as the following.
|
The Conventional Physical Therapy Program includes the following: - Indoor open environment gait training exercises (over-ground gait training exercises.). (using obstacles, cones, stepper, balance board , and uneven surfaces) (either between or outside the parallel bar) |
|
Experimental: Experimental Group
Participants in the experimental group will receive a treatment program that is comprised of two parts.
|
The C-Mill treadmill is an innovative device used for the training of impaired gait and balance.
The C-Mill is an instrumented treadmill with interactive virtual reality games and applications.The instrument is supplied with a safety frame, body weight support, treadmill force plates, treadmill belt, adjustable handrails, cameras, user operating system, interactive visual screen and augmented reality projection.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the gait parameter (stride length) (This parameter indicated the change of gait performance).
Time Frame: Data will be collected at baseline, 4 weeks after intervention commencement, and 4 weeks later, as follow up, after finishing the treatment program.
|
An electronic walkway that connected to a portable computer will be used to measure the following gait parameter: stride length (m).
|
Data will be collected at baseline, 4 weeks after intervention commencement, and 4 weeks later, as follow up, after finishing the treatment program.
|
|
Change in the gait parameter (stride time) (This parameter indicated the change of gait performance).
Time Frame: Data will be collected at baseline, 4 weeks after intervention commencement, and 4 weeks later, as follow up, after finishing the treatment program.
|
An electronic walkway that connected to a portable computer will be used to measure the following gait parameter: stride time (second).
|
Data will be collected at baseline, 4 weeks after intervention commencement, and 4 weeks later, as follow up, after finishing the treatment program.
|
|
Change in the gait parameter (cadence) (This parameter indicated the change of gait performance).
Time Frame: Data will be collected at baseline, 4 weeks after intervention commencement, and 4 weeks later, as follow up, after finishing the treatment program.
|
An electronic walkway that connected to a portable computer will be used to measure the following gait parameter: cadence (steps/ minute).
|
Data will be collected at baseline, 4 weeks after intervention commencement, and 4 weeks later, as follow up, after finishing the treatment program.
|
|
Change in the gait parameter (velocity) (This parameter indicated the change of gait performance).
Time Frame: Data will be collected at baseline, 4 weeks after intervention commencement, and 4 weeks later, as follow up, after finishing the treatment program.
|
An electronic walkway that connected to a portable computer will be used to measure the following gait parameter: velocity (meter / second).
|
Data will be collected at baseline, 4 weeks after intervention commencement, and 4 weeks later, as follow up, after finishing the treatment program.
|
|
The change in the six-minute walk test score ((This parameter indicated the change of walking tolerance abilities).
Time Frame: Data will be collected at baseline, 4 weeks after intervention commencement, and 4 weeks later, as follow up, after finishing the treatment program.
|
The six-minute walk test (6MWT) will assess the distance that the participant's ability to walk for a total of six minutes on a hard, uneven surface.
It is has been used to determine exercise tolerance changes following interventions for healthy older adults.
|
Data will be collected at baseline, 4 weeks after intervention commencement, and 4 weeks later, as follow up, after finishing the treatment program.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the Overall Stability Index {percentage value (%)}, and Time of Control {seconds} for Limit of Stability Test (test that assess the change in balance ability)
Time Frame: Data will be collected at baseline, 4 weeks after intervention commencement, and 4 weeks later, as follow up, after finishing the treatment program.
|
The Biodex Balance System will be used to assess the Change in the Overall Stability Indices of the Postural Stability Test.
The test includes measurement of the following indices: overall stability index, anteroposterior index and mediolateral index which represents the children's ability to control their postural balance stability in all directions.
High values % represent less stability and the children had difficulty in balance control.
On the other hand lower values were indicative of a better balance control.
|
Data will be collected at baseline, 4 weeks after intervention commencement, and 4 weeks later, as follow up, after finishing the treatment program.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ehab M Abd El Kafy, PhD, Department of Physical Therapy- Faculty of Applied Medical Sciences - Umm Al Qura University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22UQU428521DSR01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gait, Unsteady
-
University of PittsburghCompleted
-
University of PittsburghNational Institute on Aging (NIA)Withdrawn
-
Istituto Ortopedico GaleazziCompleted
-
Samsung Medical CenterCompletedHealthy | Gait, UnsteadyKorea, Republic of
-
Institut Robert Merle d'aubignéCompletedAmputation | Gait, UnsteadyFrance
-
University of Applied Sciences of Western SwitzerlandUnknown
-
Texas Tech University Health Sciences CenterTexas Tech UniversityWithdrawnGait, Unsteady | Accidental FallsUnited States
-
Central Arkansas Veterans Healthcare SystemCompleted
-
Samsung Medical CenterCompletedHealth Behavior | Gait, UnsteadyKorea, Republic of
-
University of MalagaCompletedChild, Only | Gait, UnsteadySpain
Clinical Trials on Conventional Physical Therapy Program
-
Cairo UniversityCompleted
-
South Valley UniversityRecruiting
-
Ragaee Saeed MahmoudRecruiting
-
Ankara UniversityCompleted
-
Cairo UniversityRecruiting
-
Cairo UniversityCompleted
-
Kutahya Health Sciences UniversityCompletedKnee OsteoarthritisTurkey
-
Sword Health, SAEmory UniversityCompleted
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompleted